寺崎真由業績

1.Sumida T, Azuma N, Moriyama M, Takahashi H, Asashima H, Honda F, Abe S, Ono Y, Hirota T, Hirata S, Tanaka Y, Shimizu T, Nakamura H, Kawakami A, Sano H, Ogawa Y, Tsubota K, Ryo K, Saito I,Tanaka A, Nakamura S, Takamura E, Tanaka M, Suzuki K, Takeuchi T, Yamakawa N, Mimori T, Ohta A, Nshiyama,S Yoshihara T, Suzuki Y, Kawano M, Tomiita M, Tsuboi H.:
Clinical practice guideline for Sjogren's syndrome 2017.
Mod Rheumatol 28(3):383-408,2018

2.Tsuboi H, Iizuka-Koga M, Asashima H, Takahashi H, Kudo H, Ono Y, Honda F, Iizuka A, Segawa S, Abe S, Yagishita M, Yokosawa M, Kondo Y, Moriyama M, Matsumoto I, Nakaramura S, Sumida T.
Up-regulation and pathogenic roles of CCL18-CCR8 axis in IgG4-related disease.
Mod Rheumatol (in press)

3.Tsuboi H, Honda F, Takahashi H, Ono Y, Abe S, Kondo Y, Matsumoto I, Sumida T.:
Pathogenesis of IgG4-related disease. Comparison with Sjogren's syndrome.
Mod Rheumatol (in press)

4.Kudo H, Tsuboi H, Asashima H, Takahashi H, Ono Y, Abe S, Honda F, Kondo Y, Wakasa Y, Takaiwa F, Takano M, Matsui M, Matsumoto I, Sumida T.:
Transgenic rice seeds expressing altered peptide ligands against the M3 muscarinic acetylcholine receptor suppress experimental sialadenitis-like Sjogren's syndrome.
Mod Rheumatol (in press)

5.Ono Y, Tsuboi H, Moriyama M, Asashima H, Kodo H, Takahashi H, Honda F, Abe S, Kondo Y, Takahashi S, Nakamura S, Matsumoto I, Sumida T.:
RORγt antagonist improves Sjogren's syndrome-like sialadenitis through downregulation of CD25.
Oral Dis. (in press)